SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ACON

Aclarion, Inc. (NASDAQ:ACON)

US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
$1.22-$0.20 (-13.92%)
 
Market cap
$3.52M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 22, 2022
Market Cap$3.52M-79.8%
Revenue (ttm)$98.56K+46.0%
Net Income-$10.11M-37.9%
EPS-$5.61+99.7%
Shares Out2.88M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,941
Open$1.25
Previous Close$1.42
Day's Range$1.22 - $1.25
52-Week Range$1.22 - $9.36
Beta1.21
AnalystsBuy
Price Targetn/a
Earnings DateMar 17, 2027
-14.08% (1D)
No price history available.

About ACON

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Address
8181 Arista Place, Broomfield, CA, 80021, US
Market Cap
4 million
Employees
11
Industrial Classification
Medical - Healthcare Information Services

Aclarion, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
8th Percentile Overall Score
ACON InsiderScore:44 / 99

Aclarion, Inc. scored higher than 8% of companies evaluated by InsiderBuying, and ranked 54th out of 57 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Aclarion, Inc. bought $4.9K of stock across 1 purchase in the last 90 days, the largest of them $4.9K.

Stake Increase

The average purchase added about 6% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$181.53K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From ACON’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-13.92%
5 Days
-21.64%
1 Month
-37.31%
6 Months
-62.50%
1 Year
-79.83%

$ACON stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ACON holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ACON's directors and management

Net Shares Purchased by Insiders−60k−30k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ACON Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ACON patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ACON from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ACON

VXFVanguard Extended Market ETF$13.22K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ACON’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
60.29
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
12
Sells
0
Buy Value
$181.53K
Distinct Buyers
7

Insider Score Trend Over Time

-2.0 since Nov 20
0255075100Nov 20 — Insider Score 46.5Nov 21 — Insider Score 44.4Nov 22 — Insider Score 44.5Nov 20Nov 21Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.